Literature DB >> 10748834

The role of radiation in delayed hearing loss in nasopharyngeal carcinoma.

A G Gibb1, K S Loh.   

Abstract

Although radiation damage to the inner ear can be induced experimentally in animals, its incidence in humans as a complication of therapy for nasopharyngeal carcinoma (NPC) remains a matter of conjecture due to inadequate histological validation. A case of advanced NPC with a mixed conductive and neurosensory hearing loss is presented that at necropsy showed tumour invasion of the VIIIth cranial nerve in the internal auditory meatus with associated infection. The architecture of the organ of Corti was well-preserved despite heavy doses of radiation but degeneration, the cause of which could not be substantiated, was present in the auditory nerve pathway. A diagnosis of radiation damage to the end-organ of hearing in the absence of supporting histological evidence should be made with caution.

Entities:  

Mesh:

Year:  2000        PMID: 10748834     DOI: 10.1258/0022215001904905

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  3 in total

1.  Hearing Loss in Patients Who Received Cranial Radiation Therapy for Childhood Cancer.

Authors:  Johnnie K Bass; Chia-Ho Hua; Jie Huang; Arzu Onar-Thomas; Kirsten K Ness; Skye Jones; Stephanie White; Shaum P Bhagat; Kay W Chang; Thomas E Merchant
Journal:  J Clin Oncol       Date:  2016-01-25       Impact factor: 44.544

2.  Cochlear implantation in postirradiated ears: A case-control comparative study.

Authors:  Waitsz Wt Chang; Kammy Nk Yeung; Betty Pk Luk; Karman Ky Leung; John Kk Sung; Michael Cf Tong
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-10-28

3.  A unique radioprotective effect of resolvin E1 reduces irradiation-induced damage to the inner ear by inhibiting the inflammatory response.

Authors:  Jie Zhang; Anting Xu; Tingting Niu; Chengcheng Liu; Yongju Zhang; Tao Li; Jihua Wang; Yongjing Wang; Dianshui Sun
Journal:  Radiat Oncol       Date:  2020-09-25       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.